©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Lipid Modifications of Trimeric G Proteins (*)

Philip B. Wedegaertner (1) (2) Paul T. Wilson (3) (4) Henry R. Bourne (1) (2)(§)

From the  (1)Departments of Pharmacology, (2)Medicine, and (3)Psychiatry, the (4)Center for Neurobiology and Psychiatry, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143

INTRODUCTION
Myristoylation and Palmitoylation of alpha Subunits
Prenylation of Subunits
Function of Lipid Modifications
Dynamic Palmitoylation
Summary
FOOTNOTES
REFERENCES


INTRODUCTION

Heterotrimeric (alphabeta) G proteins act as molecular switches to relay information from activated receptors to appropriate effector proteins (e.g. adenylyl cyclase, phosphatidylinositol-specific phospholipase C, cGMP phosphodiesterase, and ion channels). In the inactive state, the G protein exists as a heterotrimeric complex with GDP bound to the alpha subunit. Activated receptors induce exchange of GTP for GDP on the alpha subunit and dissociation of alpha from the beta dimer. Both alphabulletGTP and free beta can interact with various effector molecules. The alpha subunit's intrinsic GTP hydrolytic activity converts it back to a GDP-bound form and results in reassociation of alpha and beta; in some cases this GTPase activity is enhanced by other proteins.

Although receptor-catalyzed guanine nucleotide exchange (``turn on'') and alpha subunit GTP hydrolysis (``turn off'') are the best studied modes of G protein regulation, covalent modifications of heterotrimeric G proteins represent additional levels of regulation. This minireview will address recent advances in understanding how fatty acylation regulates the cellular localization and function of G proteins. We will present these lipid modifications within a general framework of all G proteins but also try to highlight individual differences among G proteins. Other known covalent modifications of G proteins, phosphorylation (1, 2) and bacterial toxin-catalyzed ADP-ribosylation(3) , will not be reviewed.


Myristoylation and Palmitoylation of alpha Subunits

All G protein alpha subunits are modified at or near their N termini by covalent attachment of the fatty acids myristate and/or palmitate (Fig. 1).


Figure 1: Sites of G protein lipid modification. The N-terminal sequences of several G protein alpha subunits and the C-terminal sequences of two G protein subunits are shown. Two alpha subunits of the alpha(i) family are shown; others in this family are alpha, alpha, alpha, alpha, and alpha(z). These proteins contain myristate (M) linked through an amide bond to an N-terminal glycine (after removal of the initiating methionine), as indicated by the circled boldface G. alpha(s) is not myristoylated, probably because other amino acids, particularly the asparagine at position 6, reduce the affinity of alpha(s) for N-myristoyltransferase(7) . All alpha subunits (except alpha(t)) contain palmitate (P) attached via a thioester bond to cysteine residues near the N terminus, as indicated by the boxed boldface C. The subunits are prenylated ((1) is farnesylated (F) and (2) is geranylgeranylated (GG)) through a thioether bond to a cysteine, indicated by C. After prenylation, the C-terminal three amino acids are removed (), and the new C terminus is carboxylmethylated.



Myristoylation, or more specifically N-myristoylation, is the result of co-translational addition of the saturated 14-carbon fatty acid myristate to a glycine residue at the extreme N terminus after removal of the initiating methionine. A stable amide bond links myristate irreversibly to proteins. alpha subunits of the alpha(i) family (alpha, alpha, alpha, alpha(o), alpha(z), and alpha(t)) are myristoylated (Fig. 1). The alpha subunit of transducin (alpha(t)) is heterogeneously modified at its N terminus by myristate and three other less hydrophobic fatty acids(4, 5) . This heterogeneous acylation is apparently not dictated by a unique structural feature of alpha(t) but is instead specific to retinal photoreceptor cells(6) ; the simplest explanation for such tissue-specific differences in fatty acylation of N-terminal glycines is that in different cells the fatty acyl-CoA pool contains different fatty acids(6) .

All G protein alpha subunits so far examined (except alpha(t)) contain palmitate (16-carbon, saturated fatty acid) attached through a labile, reversible thioester linkage to a cysteine near the N terminus (Fig. 1). In contrast to myristoylation(7) , the biochemistry of palmitoylation is not well understood.

Several alpha subunits contain both myristate and palmitate (Fig. 1). Although the presence of both fatty acids on the same protein molecule has not been directly shown, preventing myristoylation of alpha(i), alpha(o), or alpha(z) by mutation of glycine to alanine also appears to prevent palmitoylation of the alpha subunits(8, 9, 10) . A similar requirement of prior myristoylation for palmitoylation has been observed for several non-receptor tyrosine kinases(11, 12) . Thus, the sequence M-G-C may represent a signal for dual acylation of certain G protein alpha subunits(13) . In contrast, alpha(s) does not require myristoylation for palmitoylation, although it does have the sequence M-G-C, and other alpha subunits (e.g. alpha(q), alpha, alpha) are palmitoylated on cysteine residues within diverse sequence contexts. Furthermore, recent evidence indicates that prior myristoylation may not be an absolute prerequisite for palmitoylation: a G2A mutant of alpha incorporates palmitate if G protein beta subunits are co-expressed(14) . In addition, a G2A mutant of alpha(z) or alpha is palmitoylated when overexpressed in Chinese hamster ovary cells. (^1)Taken together, the available data suggest that myristoylation and/or binding to beta (or other unknown factors) directs the alpha subunits to a membrane location where palmitoylation occurs (discussed below).

Although it is often assumed that alpha subunits are uniquely modified by palmitate on certain cysteine residues, different alpha subunits may contain other thioester-linked fatty acids in different cells. In this regard, several alpha subunits in platelets can incorporate thioester-linked arachidonate in addition to palmitate(15) .


Prenylation of Subunits

G protein subunits are covalently modified by the 20-carbon isoprenoid geranylgeranyl or, in the case of retinal-specific (1), the 15-carbon isoprenoid farnesyl (Fig. 1). As with other prenylated proteins, the geranylgeranyl or farnesyl moiety is attached via a stable thioether bond to a cysteine residue located in the C-terminal ``CAAX'' box of . This is followed by proteolytic removal of the C-terminal three amino acids and then by carboxyl methylation at the new C terminus. The enzymology and substrate requirements of prenylation have been well reviewed recently (e.g.(16) ).

A recent study (17) addressed the temporal order of beta dimer formation and processing of . Farnesylation or geranylgeranylation of the appropriate is not required for beta dimerization; however, a proteolytically truncated isoprenylated (lacking the C-terminal three amino acids) was incapable of interacting with a beta subunit, indicating that assembly of an isoprenylated beta dimer occurs prior to proteolysis and carboxyl methylation of the subunit (17) . Although mutant non-prenylated can form a stable dimer with beta (reviewed in (18) ), prenylation of is necessary for normal function of the beta dimer (discussed below). To date no lipid modification has been identified on G protein beta subunits.


Function of Lipid Modifications

For G proteins, as well as other lipid-modified proteins, attached lipids appear to direct interaction with both membrane lipids and other proteins. How can a covalently attached lipid perform such strikingly different roles? This is a conceptually difficult and unanswered question. It is instructive, therefore, to consider distinct, though not mutually exclusive, models to explain how attached lipids may affect both protein-membrane and protein-protein interactions (Fig. 2).


Figure 2: Models for lipid mediated protein-membrane and proteinprotein interactions. A, a lipid attached to a protein may insert directly into the membrane lipid bilayer. B, the attached lipid may bind to a hydrophobic pocket in another protein. C, the attached lipid may remain in the membrane lipid bilayer and specifically interact with another protein. D, the lipid may interact with the protein to which it is covalently attached and thereby stabilize a conformation that is competent to bind another protein.



Lipid Modifications Affect Membrane Attachment of G Proteins

An obvious function for fatty acylation is to act as a hydrophobic membrane anchor. Recent data suggest that both palmitoylation and myristoylation contribute to membrane association, with palmitoylation, due to its greater hydrophobicity, providing a stronger association with membrane lipids. Mutagenesis studies indicated that myristoylation was required for membrane localization of alpha(i) and alpha(o)(19, 20) ; however, those studies predated the realization that alpha(i) and alpha(o) are also palmitoylated. More recently, expression of myristoylated but not palmitoylated C3A alpha(o)(9) , C3S alpha(8) , or C3S alpha(o)(21) resulted in significant increases (compared with wild type) in the amounts of each protein in the soluble (or cytosolic) fraction. alpha(t), probably the only alpha subunit that does not contain palmitate (Fig. 1), is unique in its ability to be released from membranes in the absence of detergents.

Studies of alpha subunits that normally contain palmitate but not myristate provide further evidence for the importance of palmitoylation in membrane attachment. Non-palmitoylated mutants of alpha(s), alpha(q), and alpha exhibited markedly decreased abilities to associate with membranes(22, 23) .

The mechanism by which lipid modification enhances the membrane association of G protein subunits has not been determined. The simplest explanation is that the fatty acids or prenyl groups insert directly into the hydrophobic membrane lipids and thus anchor the protein at the membrane. In this regard, in vitro measurements of the affinity of acylated peptides for lipid vesicles correlate with observations of mutant G proteins in cells. Myristate provides barely enough energy to anchor a protein to membranes, and other factors, such as positive charges and protein-protein interactions, would be required to efficiently anchor myristoylated proteins. On the other hand, palmitate has sufficient binding energy to stably anchor a protein to membranes(24) . This is exactly what is seen with lipid modified alpha subunits; where examined, palmitoylated alpha subunits have been found in the particulate (microsomal membrane) fraction of cells, while myristoylated (but not palmitoylated) alpha subunits vary in their degree of association with membranes. Direct insertion of the lipid moieties into membranes remains the simplest model (Fig. 2A) to account for the effects of fatty acylation on membrane attachment, although no compelling evidence rules out the possibility that a membrane-bound ``docking protein'' specifically binds fatty acids linked to alpha subunits.

Other factors, however, help guide alpha subunits to membranes. The most obvious example of such a protein is the G protein beta dimer(25) , which may even serve as a membrane-bound docking protein. Co-expression of beta with alpha led to more membrane-bound and functional alpha than if alpha was expressed alone(26) . A putative palmitoyltransferase is another example of a protein that may direct alpha subunits to membranes; that is, non-palmitoylated alpha subunits would bind a membrane-bound palmitoyltransferase, become palmitoylated, and then would be capable of directly binding to membranes. Thus, binding to other proteins probably contributes to the appropriate cellular localization of the G protein alpha subunits.

Like fatty acylation of alpha subunits, prenylation of chains is required for correct membrane targeting of the beta dimer. Expression of mutant non-prenylated with beta in cultured cells produced beta dimers that were located in the cytosolic rather than in the membrane fraction(18) .

Again, peptide studies are relevant in considering mechanisms of beta membrane association. For attachment of a peptide to lipid vesicles in vitro, a farnesyl group provides binding energy quantitatively similar to that of myristate(27) . To supplement this relatively low binding energy, the farnesyl group may specifically interact with an integral membrane protein, as postulated for diverse prenylated proteins(28) . Indeed, the alpha subunits may play such a role, since prenylation of is required for beta binding to alpha. On the other hand, the more hydrophobic geranylgeranyl group is sufficient by itself to stably anchor a protein to membranes(27) . In agreement, farnesylated beta(1)(1) dimers, but not geranylgeranylated beta dimers, are soluble in the absence of detergents. A high affinity, heat- and protease-sensitive binding site has been identified for prenylated peptides in a microsomal membrane preparation(29) . This binding activity was not found in the plasma membrane; it may play a role in targeting prenylated proteins to a membrane compartment where C-terminal proteolysis and carboxyl methylation occur.

The presence of a methyl group at the C terminus of is important for membrane attachment of farnesylated retinal beta(1)(1)(30) . Similarly, carboxyl methylation increased the affinity of a farnesylated peptide for lipid vesicles more than 10-fold(27) . Thus, carboxyl methylation also contributes to beta membrane association, probably by neutralizing the negatively charged C terminus.

In summary, membrane association of G protein subunits is a complex process involving multiple interactions. A combination of covalent lipid modifications and specific protein-protein interactions is essential for membrane-attached and functional G proteins. The diverse combinations of lipid modifications of alpha subunits (Fig. 1) may account for different subcellular localizations of different alpha subunits. G proteins have recently been detected in plasma membrane domains termed caveolae(31, 32, 33) . Palmitoylation is required for the caveolar localization of certain members of the Src family of tyrosine kinases(11) (^2); alpha subunits may similarly require palmitate for localization to caveolae. In addition, alpha subunits are not located only in the plasma membrane (2) but have been detected at other intracellular membrane sites, including the Golgi apparatus and endoplasmic reticulum. We can speculate that different attached lipids direct G proteins to unique cellular membranes.

Lipid Modifications and G Protein Function

Besides functioning as membrane anchors, what role do attached myristate and palmitate play in the biological activities of alpha subunits and their interactions with other proteins? Table 1summarizes strong evidence that myristoylation greatly increases the affinity of the alpha(i) family of subunits for beta. Crystal structures of myristoylated alpha bound to beta will show whether the attached myristate interacts directly with beta or stabilizes a conformation of alpha competent to interact with beta (Fig. 2BversusFig. 2D). In either case, the fact that myristate linked to alpha is required for its interaction with beta in membrane-free systems (Table 1) raises the possibility, noted above, that beta serves as a key docking protein that accounts, at least partially, for the binding of myristoylated alpha to membranes.



Recent studies suggest that palmitoylation is less important than myristoylation for alpha subunit interaction with beta, although the relative affinity of non-palmitoylated alpha versus wild type alpha for beta has not been rigorously addressed. A myristoylated but non-palmitoylated C3S alpha(o) mutant was a target for beta-dependent pertussis toxin-catalyzed ADP-ribosylation in intact cells(21) , and a myristoylated but non-palmitoylated C3A alpha mutant was a better substrate for beta-dependent ADP-ribosylation than a non-myristoylated and non-palmitoylated G2A mutant alpha in a cell-free assay(14) .

Besides binding to beta subunits, lipid modifications of alpha may affect its interaction with other proteins (Table 1). One of the best examples is the demonstration that myristoylation of alpha(i) is required for its inhibition of adenylyl cyclase in a cell-free assay (34) . As in the case of alpha binding to beta, the mechanism by which myristate confers upon purified alpha(i) the ability to productively interact with adenylyl cyclase has not been determined.

Mutation of alpha subunit lipid modification sites and analysis of activity in transfected cells has provided further evidence that fatty acylation is important for biological activity. A G2A mutation of a constitutively active form of alpha abolished its biological activity(35) . Since the G2A mutation probably blocked palmitoylation in addition to myristoylation, the contribution of each attached fatty acid is not clear. In contrast, non-myristoylated G2A alpha(z) retains the ability to inhibit adenylyl cyclase in transfected cells.^1 In another study(22) , a non-palmitoylated C9S,C10S alpha(q) completely lacked the ability to stimulate its effector, phospholipase C. Whether these effects are due to a requirement for the attached fatty acid in protein-protein interactions or are secondary to decreased membrane association of alpha subunits remains unknown. Direct reconstitution of purified palmitoylated versus non-palmitoylated alpha subunits will help resolve this issue. Such studies are hampered, however, by the difficulty of purifying stoichiometrically palmitoylated alpha subunits because of the lability of this covalent modification.

Although not required for beta dimer formation, prenylation is absolutely necessary for productive interactions of beta with alpha subunits, receptors, and effectors (16, 18) (Table 1). In addition, carboxyl methylation of farnesylated beta(1)(1) also enhances its ability to interact with alpha(t) and rhodopsin(30, 36) . Prenylation clearly provides more than merely a membrane anchor (Table 1). For the G protein beta subunit, as with other proteins like the Ras superfamily of guanine nucleotide-binding proteins(28) , prenylation is indispensable for many protein-protein interactions.


Dynamic Palmitoylation

An important aspect of palmitoylation is its biological reversibility and consequent potential for regulation. Indeed, the turnover of palmitate attached to alpha(s) is dramatically affected by alpha(s) activation. Activation of alpha(s) in COS cells by beta-adrenergic receptor stimulation (9, 37) or directly with cholera toxin (37) led to an increase in its palmitate labeling. The increased labeling suggested a faster turnover of palmitate attached to activated (GTP-bound) alpha(s), and indeed, beta-adrenergic receptor activation caused a slightly more rapid depalmitoylation of alpha(s) in a pulse-chase experiment(9) . This was confirmed by analyzing the palmitate turnover of alpha(s) in S49 cells. In these cells, palmitate attached to alpha(s) exhibited a half-life of 90 min, whereas activation of the beta-adrenergic receptor caused the attached palmitate to turn over very rapidly (t approx 2 min)(38) ; in COS cells, palmitate on a similarly activated alpha(s) turned over with a half-life of 30 min(9) . Palmitate attached to a mutationally activated alpha(s) in S49 cells also turns over with a rapidity similar to that of receptor-activated alpha(s)(38) . This activation-induced rapid depalmitoylation of alpha(s) correlates with and is probably the mechanism for activation-induced translocations of alpha(s) from membranes to cytosol observed previously (39, 40) (Fig. 3). Moreover, a mutant non-palmitoylated alpha(s) could not mediate hormonal stimulation of its effector, adenylyl cyclase(22) . This raises the possibility that depalmitoylation of alpha(s) provides a physiologically relevant way to damp or turn off G protein signals, in addition to better established mechanisms (hydrolysis of GTP bound to alpha, desensitization of receptors, etc.).


Figure 3: Model of alpha(s) depalmitoylation and membrane release. In the unactivated state, alpha(s)bulletGDP (square) associates with beta and the plasma membrane. Receptor activation (R*) stimulates dissociation of GDP from alpha(s) and formation of active alpha(s)bulletGTP (diamond). alpha(s)bulletGTP and beta dissociate from each other but remain at the plasma membrane by virtue of their attached palmitate and isoprenyl groups, respectively. Palmitate is rapidly cleaved from activated alpha(s)bulletGTP by a palmitoyl thioesterase, however, and alpha(s) is released from the membrane. Intrinsic GTP hydrolysis converts both membrane and cytoplasmic alpha(s)bulletGTP into the inactive GDP-bound form. Palmitoylation by a palmitoyltransferase facilitates the return of alpha(s)bulletGDP to the plasma membrane. Although the model depicts palmitoylation of alpha(s) as preceding its association with beta, the temporal order of these two events is unknown.



Thus, regulated palmitoylation of alpha(s) (and possibly other alpha subunits) can control its cellular location and activity (Fig. 3). One future challenge will be to explore how different cellular locations of alpha subunits affect their activities. A second major challenge will be that of explaining the molecular basis of these cycles of palmitoylation and depalmitoylation (Fig. 3). Little is known about the enzymes involved. Palmitoyltransferase activity has only been detected in crude extracts. A palmitoyl thioesterase capable of removing palmitate from H-ras or G protein alpha subunits has been purified to homogeneity (41) but is primarily secreted from cells (42) and thus unlikely to be responsible for depalmitoylating G protein alpha subunits in vivo.

Although myristoylation is assumed to be a stable, irreversible modification, two recent reports suggest the possibility of regulated myristoylation. First, Gpa1, a yeast G protein alpha subunit that functions in the pheromone response pathway, exists in both a myristoylated and non-myristoylated form in yeast cells. Pheromone activation leads to an increase in the fraction of newly synthesized Gpa1 that is myristoylated(43) . Second, a demyristoylase activity capable of removing myristate from the protein kinase C substrate MARCKS has been described(44) .


Summary

G protein alpha subunits and beta dimers are covalently modified by lipids. The emerging picture is one in which attached lipids provide more than just a nonspecific ``glue'' for sticking G proteins to membranes. We are only beginning to understand how different lipid modifications of different G protein subunits affect specific protein-protein interactions and localization to specific cellular sites. In addition, regulation of these modifications, particularly palmitoylation, can provide new ways to regulate signals transmitted by G proteins.


FOOTNOTES

*
This minireview will be reprinted in the 1995 Minireview Compendium, which will be available in December, 1995. This work was supported by American Cancer Society Fellowship PF-3776 (to P. B. W.), grants from NARSAD and NIMH (to P. T. W.), NIH Grants GM-27800 and CA-54427 (to H. R. B.), and a grant from the March of Dimes (to H. R. B.).

§
To whom correspondence should be addressed: S-1212, Box 0450, UC Medical Center, San Francisco, CA 94143. Tel.: 415-476-8161; Fax: 415-476-5292.

(^1)
P. T. Wilson, manuscript in preparation.

(^2)
S. Robbins, N. Quintrell, and J. M. Bishop, personal communication.


REFERENCES

  1. Houslay, M. D. (1991) Cell. Signalling 3, 1-9 [Medline] [Order article via Infotrieve]
  2. Jones, T. L. Z. (1994) in G Proteins , (Spiegel, A. M., Jones, T. L. Z., Simonds, W. F., and Weinstein, L. S., eds) pp. 49-65, R. G. Landes Co., Austin, TX
  3. Moss, J., and Vaughan, M. (1990) ADP-ribosylating Toxins and G Proteins: Insights into Signal Transduction , American Society for Microbiology, Washington, D. C.
  4. Kokame, K., Fukada, Y., Yoshizawa, T., Takao, T., and Shimonishi, Y. (1992) Nature 359, 749-752 [CrossRef][Medline] [Order article via Infotrieve]
  5. Neubert, T. A., Johnson, R. S., Hurley, J. B., and Walsh, K. A. (1992) J. Biol. Chem. 267, 18274-18277 [Abstract/Free Full Text]
  6. Johnson, R. S., Ohguro, H., Palczewski, K., Hurley, J. B., Walsh, K. A., and Neubert, T. A. (1994) J. Biol. Chem. 269, 21067-21071 [Abstract/Free Full Text]
  7. Gordon, J. I., Duronio, R. J., Rudnick, D. A., Adams, S. P., and Gokel, G. W. (1991) J. Biol. Chem. 266, 8647-8650 [Free Full Text]
  8. Galbiati, F., Guzzi, F., Magee, A. I., Milligan, G., and Parenti, M. (1994) Biochem. J., 303, 697-700 [Medline] [Order article via Infotrieve]
  9. Mumby, S. M., Kleuss, C., and Gilman, A. G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2800-2804 [Abstract]
  10. Hallak, H., Brass, L. F., and Manning, D. R. (1993) J. Biol. Chem. 269, 4571-4576 [Abstract/Free Full Text]
  11. Shenoy-Scaria, A. M., Dietzen, D. J., Kwong, J., Link, D. C., and Lublin, D. M. (1994) J. Cell Biol. 126, 353-363 [Abstract]
  12. Rodgers, W., Crise, B., and Rose, J. K. (1994) Mol. Cell. Biol. 14, 5384-5391 [Abstract]
  13. Parenti, M., Vigano, M. A., Newman, C. M. H., Milligan, G., and Magee, A. I. (1993) Biochem. J. 291, 349-353 [Medline] [Order article via Infotrieve]
  14. Degtyarev, M. Y., Spiegel, A. M., and Jones, T. L. Z. (1994) J. Biol. Chem. 269, 30898-30903 [Abstract/Free Full Text]
  15. Hallak, H., Muszbek, L., Laposata, M., Belmonte, E., Brass, L. F., and Manning, D. R. (1994) J. Biol. Chem. 269, 4713-4716 [Abstract/Free Full Text]
  16. Casey, P. J., Moomaw, J. F., Zhang, F. L., Higgins, J. B., and Thissen, J. A. (1994) Recent Prog. Horm. Res. 49, 215-238 [Medline] [Order article via Infotrieve]
  17. Higgins, J. B., and Casey, P. J. (1994) J. Biol. Chem. 269, 9067-9073 [Abstract/Free Full Text]
  18. Simonds, W. F. (1994) in G Proteins , (Spiegel, A. M., Jones, T. L. Z., Simonds, W. F., and Weinstein, L. S., eds) pp. 95-106, R. G. Landes Co., Austin, TX
  19. Jones, T. L., Simonds, W. F., Merendino, J. J., Brann, M. R., and Spiegel, A. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 568-572 [Abstract]
  20. Mumby, S. M., Heukeroth, R. O., Gordon, J. I., and Gilman, A. G. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 728-732 [Abstract]
  21. Grassie, M. A., McCallum, J. F., Guzzi, F., Magee, A. I., Milligan, G., and Parenti, M. (1994) Biochem. J. 302, 913-920 [Medline] [Order article via Infotrieve]
  22. Wedegaertner, P. B., Chu, D. H., Wilson, P. T., Levis, M. J., and Bourne, H. R. (1993) J. Biol. Chem. 268, 25001-25008 [Abstract/Free Full Text]
  23. McCallum, J. F., Wise, A., Parenti, M., and Milligan, G. (1994) Biochem. Soc. Trans. , in press
  24. Peitzsch, R. M., and McLaughlin, S. (1993) Biochemistry 32, 10436-10443 [Medline] [Order article via Infotrieve]
  25. Sternweis, P. C. (1986) J. Biol. Chem. 261, 631-637 [Abstract/Free Full Text]
  26. Linder, M. E., Middleton, P., Hepler, J. R., Taussig, R., Gilman, A. G., and Mumby, S. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3675-3679 [Abstract]
  27. Silvius, J. R., and l'Heureux, F. (1994) Biochemistry 33, 3014-3022 [Medline] [Order article via Infotrieve]
  28. Marshall, C. J. (1993) Science 259, 1865-1866 [Medline] [Order article via Infotrieve]
  29. Thissen, J. A., and Casey, P. J. (1993) J. Biol. Chem. 268, 13780-13783 [Abstract/Free Full Text]
  30. Fukada, Y., Matsuda, T., Kokame, K., Takao, T., Shimonishi, Y., Akino, T., and Yoshizawa, T. (1994) J. Biol. Chem. 269, 5163-5170 [Abstract/Free Full Text]
  31. Sargiacomo, M., Sudol, M., Tang, Z., and Lisanti, M. P. (1993) J. Cell Biol. 122, 789-807 [Abstract]
  32. Lisanti, M. P., Scherer, P. E., Vidurigiene, J., Tang, Z., HermanowskiVosatka, A., Tu, Y.-H., Cook, R. F., and Sargiacomo, M. (1994) J. Cell Biol. 126, 111-126 [Abstract]
  33. Chang, W.-J., Ying, Y.-S., Rothberg, K. G., Hooper, N. M., Turner, A. J., Gambliel, H. A., De Gunzburg, J., Mumby, S. M., Gilman, A. G., and Anderson, R. G. W. (1994) J. Cell Biol. 126, 127-138 [Abstract]
  34. Taussig, R., Iñiguez-Lluhi, J. A., and Gilman, A. G. (1993) Science 261, 218-221 [Medline] [Order article via Infotrieve]
  35. Gallego, C., Gupta, S. K., Winitz, S., Eisfelder, B. J., and Johnson, G. L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9695-9699 [Abstract]
  36. Ohguro, H., Fukada, Y., Takao, T., Shimonishi, Y., Yoshizawa, T., and Akino, T. (1991) EMBO J. 10, 3669-3674 [Abstract]
  37. Degtyarev, M. Y., Spiegel, A. M., and Jones, T. L. Z. (1993) J. Biol. Chem. 268, 23769-23772 [Abstract/Free Full Text]
  38. Wedegaertner, P. B., and Bourne, H. R. (1994) Cell 77, 1063-1070 [Medline] [Order article via Infotrieve]
  39. Levis, M. J., and Bourne, H. R. (1992) J. Cell Biol. 119, 1297-1307 [Abstract]
  40. Ransnäs, L. A., Svoboda, P., Jasper, J. R., and Insel, P. A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7900-7903 [Abstract]
  41. Camp, L. A., and Hofmann, S. L. (1993) J. Biol. Chem. 268, 22566-22574 [Abstract/Free Full Text]
  42. Camp, L. A., Verkruyse, L. A., Afendis, S. J., Slaughter, C. A., and Hofmann, S. L. (1994) J. Biol. Chem. 269, 23212-23219 [Abstract/Free Full Text]
  43. Dohlman, H. G., Goldsmith, P., Spiegel, A. M., and Thorner, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9688-9692 [Abstract]
  44. Maneti, S., Sorokine, O., Van Dorsselaer, A., and Taniguchi, H. (1994) J. Biol. Chem. 269, 8309-8313 [Abstract/Free Full Text]
  45. Linder, M. E., Pang, I.-H., Duronio, R. J., Gordon, J. I., Sternweis, P. C., and Gilman, A. G. (1991) J. Biol. Chem. 266, 4654-4659 [Abstract/Free Full Text]
  46. Iñiguez-Lluhi, J. A., Simon, M. I., Robishaw, J. D., and Gilman, A. G. (1992) J. Biol. Chem. 267, 23409-23417 [Abstract/Free Full Text]
  47. Dietrich, A., Meister, M., Brazil, D., Camps, M., and Gierschik, P. (1994) Eur. J. Biochem. 219, 171-178 [Abstract]
  48. Kisselev, O. G., Ermolaeva, M. V., and Gautam, N. (1994) J. Biol. Chem. 269, 21399-21402 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.